{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:17:39Z","timestamp":1787066259383,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1124\/dmd.111.038562","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T23:17:31Z","timestamp":1299107851000},"page":"966-973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suppression of Cytochrome P450 Reductase (POR) Expression in Hepatoma Cells Replicates the Hepatic Lipidosis Observed in Hepatic POR-Null Mice"],"prefix":"10.1016","volume":"39","author":[{"given":"Todd D.","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashis","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta I.","family":"Stolarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.038562_bib1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1073\/pnas.98.4.1477","article-title":"Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands","volume":"98","author":"DeBose-Boyd","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.111.038562_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20080740","article-title":"Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway","volume":"417","author":"Finn","year":"2009","journal-title":"Biochem J"},{"key":"10.1124\/dmd.111.038562_bib3","doi-asserted-by":"crossref","first-page":"25895","DOI":"10.1074\/jbc.M303125200","article-title":"Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase","volume":"278","author":"Gu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.038562_bib4","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1074\/jbc.M212087200","article-title":"Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase","volume":"278","author":"Henderson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.038562_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","article-title":"LXRS and FXR: the yin and yang of cholesterol and fat metabolism","volume":"68","author":"Kalaany","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/dmd.111.038562_bib6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bbalip.2009.07.006","article-title":"Es-x\/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes","volume":"1791","author":"Ko","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.111.038562_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/abbi.2000.1985","article-title":"Expression of cholesterol 7alpha-hydroxylase restores bile acid synthesis in McArdle RH7777 cells","volume":"381","author":"Labont\u00e9","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.111.038562_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2007.02.010","article-title":"Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase","volume":"461","author":"Li","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.111.038562_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"Pt 2","key":"10.1124\/dmd.111.038562_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/jcs.96.2.231","article-title":"Increased gap junction assembly between cultured cells upon cholesterol supplementation","volume":"96","author":"Meyer","year":"1990","journal-title":"J Cell Sci"},{"key":"10.1124\/dmd.111.038562_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbi.2010.01.008","article-title":"Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile","volume":"184","author":"Moya","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.111.038562_bib12","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/pr0700448","article-title":"The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism","volume":"6","author":"Mutch","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.111.038562_bib13","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/MCB.23.17.6103-6116.2003","article-title":"Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis","volume":"23","author":"Otto","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.111.038562_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbalip.2004.02.002","article-title":"Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes","volume":"1682","author":"Rasouli","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.111.038562_bib15","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/MCB.01638-08","article-title":"Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb","volume":"29","author":"Schmidt","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.111.038562_bib16","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1074\/jbc.M111408200","article-title":"Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase","volume":"277","author":"Shen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.038562_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1124\/dmd.111.038562_bib18","doi-asserted-by":"crossref","first-page":"759S","DOI":"10.1093\/jn\/136.3.759S","article-title":"Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis","volume":"136","author":"Singh","year":"2006","journal-title":"J Nutr"},{"key":"10.1124\/dmd.111.038562_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-2275(20)40625-X","article-title":"A comparison of delipidated sera used in studies of sterol synthesis by human mononuclear leukocytes","volume":"20","author":"Slater","year":"1979","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.111.038562_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/BJ20042087","article-title":"Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice","volume":"388","author":"Wang","year":"2005","journal-title":"Biochem J"},{"key":"10.1124\/dmd.111.038562_bib21","doi-asserted-by":"crossref","first-page":"31686","DOI":"10.1074\/jbc.M504447200","article-title":"Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype","volume":"280","author":"Weng","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.111.038562_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","article-title":"FXR signaling in metabolic disease","volume":"582","author":"Zhang","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.111.038562_bib23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1194\/jlr.M001586","article-title":"Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake","volume":"51","author":"Zhu","year":"2010","journal-title":"J Lipid Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.038562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T13:42:16Z","timestamp":1739886136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624057763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0090955624057763"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.038562","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of Cytochrome P450 Reductase (POR) Expression in Hepatoma Cells Replicates the Hepatic Lipidosis Observed in Hepatic POR-Null Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.038562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}